Yeast Genomics and Drug Target Identification

Author(s): Nike Bharucha, Anuj Kumar*

Journal Name: Combinatorial Chemistry & High Throughput Screening
Accelerated Technologies for Biotechnology, Bioassays, Medicinal Chemistry and Natural Products Research

Volume 10 , Issue 8 , 2007

Become EABM
Become Reviewer
Call for Editor


The budding yeast Saccharomyces cerevisiae is well recognized as a preferred eukaryote for the development of genomic technologies and approaches. Accordingly, a sizeable complement of genomic resources has been developed in yeast, and this genomic foundation is now informing a wide variety of disciplines. In particular, yeast genomic methodologies are gaining an expanding foothold in drug development studies, most notably as a preliminary tool towards drug target identification. In this review, we highlight many applications of yeast genomics in the identification of targeted genes and pathways of small molecules or therapeutic drugs. The applicability of genome-wide resources of yeast disruption and deletion mutants for drug-sensitivity/resistance screening is presented here, along with a summary of microarray technologies for drug-based transcriptional profiling and synthetic interaction mapping. Applications of proteininteraction traps for potential drug target identification are also considered. Collectively, this overview of yeast genomics emphasizes the growing intersection between high-throughput model organism biology and medicinal chemistry — an intersection promising tangible advances for both academic and pharmaceutical fields alike.

Keywords: Yeast, genomics, proteomics, DNA microarray, synthetic interaction, two-hybrid assay

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [618 - 634]
Pages: 17
DOI: 10.2174/138620707782507340

Article Metrics

PDF: 45